id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-D-0244-0001,FDA,FDA-2003-D-0244,FDA,Notice,NAD-Notice of Availability of Data,2003-12-30T05:00:00Z,2003,12,2003-12-30T05:00:00Z,2004-03-02T04:59:59Z,2008-04-12T00:55:07Z,,0,0,090000648048ecd0
FDA-2003-N-0096-0001,FDA,FDA-2003-N-0096,Revision of the Requirements for Spore-Forming Microorganisms,Notice,NPR-Notice of Proposed Rule-Making,2003-12-30T05:00:00Z,2003,12,2003-12-30T05:00:00Z,2004-03-16T04:59:59Z,2025-06-19T09:00:11Z,03-31919,0,0,09000064804838aa
FDA-2002-D-0022-0004,FDA,FDA-2002-D-0022,FDA,Notice,NAD-Notice of Availability of Data,2003-12-30T05:00:00Z,2003,12,2003-12-19T05:00:00Z,2004-12-20T04:59:59Z,2008-04-12T01:16:13Z,,0,0,0900006480488e14
FDA-2000-N-0139-0002,FDA,FDA-2000-N-0139,Agency Information Collection Activities; Comment Request; Guidance for Industry-Changes to an Approved New Drug Application or Abbreviated New Drug Application,Notice,General Notice,2003-12-30T05:00:00Z,2003,12,2003-12-19T05:00:00Z,2004-02-18T04:59:59Z,2025-06-12T20:08:33Z,03-31412,0,0,09000064804d0bb0
FDA-2003-D-0428-0001,FDA,FDA-2003-D-0428,FDA,Notice,NAD-Notice of Availability of Data,2003-12-30T05:00:00Z,2003,12,2003-12-19T05:00:00Z,2004-12-20T04:59:59Z,2008-04-12T00:55:43Z,,0,0,09000064804a21c9
FDA-2003-N-0096-0002,FDA,FDA-2003-N-0096,Revision of the Requirements For Spore-Forming Microorganisms; Companion to Direct Final Rule,Notice,Notice of Final Rule,2003-12-30T05:00:00Z,2003,12,2003-12-30T05:00:00Z,2004-03-16T04:59:59Z,2025-06-18T19:14:55Z,03-31918,0,0,09000064804838f1
FDA-2002-D-0023-0004,FDA,FDA-2002-D-0023,FDA,Notice,NAD-Notice of Availability of Data,2003-12-18T05:00:00Z,2003,12,2003-12-17T05:00:00Z,2004-12-19T04:59:59Z,2008-04-12T01:16:14Z,,0,0,0900006480488ef4
FDA-2002-D-0023-0005,FDA,FDA-2002-D-0023,FDA,Notice,NAD-Notice of Availability of Data,2003-12-18T05:00:00Z,2003,12,2003-12-17T05:00:00Z,2004-12-19T04:59:59Z,2008-04-12T01:16:14Z,,0,0,0900006480488ef6
FDA-2002-N-0064-0003,FDA,FDA-2002-N-0064,Neurological Devices; Classification of Human Dura Mater,Notice,Notice of Final Rule,2003-12-18T00:00:00Z,2003,12,2003-12-18T05:00:00Z,,2025-05-13T07:52:58Z,03-31174,0,0,090000648048c4de
FDA-2003-D-0186-0005,FDA,FDA-2003-D-0186,FDA,Notice,NAD-Notice of Availability of Data,2003-12-17T05:00:00Z,2003,12,2003-12-17T05:00:00Z,,2008-04-12T00:54:52Z,,0,0,090000648048a872
FDA-2002-N-0064-0002,FDA,FDA-2002-N-0064,Neurological Devices; Classification of Human Dura Mater,Notice,Notice of Final Rule,2003-12-17T05:00:00Z,2003,12,2003-12-18T05:00:00Z,,2025-05-13T07:51:26Z,03-31174,0,0,090000648048c4db
FDA-2003-D-0186-0004,FDA,FDA-2003-D-0186,FDA,Notice,NAD-Notice of Availability of Data,2003-12-17T05:00:00Z,2003,12,2003-12-17T05:00:00Z,,2008-04-12T00:54:52Z,,0,0,090000648048a86f
FDA-2000-N-0224-0004,FDA,FDA-2000-N-0224,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Notice of Approval,Notice,Notice of Approval,2003-12-16T05:00:00Z,2003,12,2003-12-16T05:00:00Z,,2015-12-09T14:52:39Z,,0,0,09000064804d542a
FDA-2003-N-0383-0001,FDA,FDA-2003-N-0383,Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notification Submissions,Notice,60 Day Proposed Information Collection,2003-12-16T05:00:00Z,2003,12,2003-12-16T05:00:00Z,2004-02-18T04:59:59Z,2025-06-23T18:52:24Z,03-30964,0,0,090000648049a1f9
FDA-2002-N-0233-0083,FDA,FDA-2002-N-0233,FDA,Notice,NAD-Notice of Availability of Data,2003-12-16T05:00:00Z,2003,12,2003-12-12T05:00:00Z,2004-12-17T04:59:59Z,2008-04-12T01:23:40Z,,0,0,0900006480498809
FDA-2003-N-0157-0004,FDA,FDA-2003-N-0157,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry: Submitting and Reviewing Complete Responses to Clinical Holds,Notice,Notice of Approval,2003-12-16T05:00:00Z,2003,12,,,2025-02-27T17:09:04Z,03-30963,0,0,0900006480487917
FDA-2003-D-0435-0001,FDA,FDA-2003-D-0435,Compliance Policy Guide Sec. 110.3 10 - “Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002;” Availability,Notice,NAD-Notice of Availability of Data,2003-12-15T05:00:00Z,2003,12,2003-12-15T05:00:00Z,,2009-03-10T21:04:02Z,,0,0,09000064804a234b
FDA-2002-N-0233-0081,FDA,FDA-2002-N-0233,FDA,Notice,NAD-Notice of Availability of Data,2003-12-15T05:00:00Z,2003,12,2003-12-12T05:00:00Z,,2008-04-12T01:23:22Z,,0,0,0900006480498804
FDA-2002-N-0323-0076,FDA,FDA-2002-N-0323,Small Entity Compliance Guides on Registration of Food Facilities and Prior Notice of Imported Food,Notice,NAD-Notice of Availability of Data,2003-12-15T05:00:00Z,2003,12,2003-12-12T05:00:00Z,,2009-10-27T19:46:17Z,,0,0,09000064804a09c9
FDA-2003-N-0301-0001,FDA,FDA-2003-N-0301,FDA,Notice,NPH-Notice of Opportunity of Hearing,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-09-09T03:59:59Z,2008-04-12T01:00:02Z,,0,0,0900006480493d43
FDA-2003-N-0102-0003,FDA,FDA-2003-N-0102,Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing; Correction,Notice,NCR-Notice of Correction,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-11-07T04:59:59Z,2009-08-10T22:30:15Z,,0,0,09000064804840c3
FDA-2003-N-0162-0001,FDA,FDA-2003-N-0162,"Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in the New Animal Drug Regulations; Drug Efficacy Study
Implementation; Notice of Opportunity for Hearing",Notice,Notice of Opportunity of Hearing,2003-12-12T05:00:00Z,2003,12,,,2025-03-14T14:16:37Z,03-20241,0,0,0900006480488554
FDA-2003-N-0301-0002,FDA,FDA-2003-N-0301,FDA,Notice,NCR-Notice of Correction,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-11-07T04:59:59Z,2008-04-12T01:00:02Z,,0,0,0900006480493da5
FDA-2003-N-0300-0001,FDA,FDA-2003-N-0300,"Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in the New Animal Drug Regulations; Drug Efficacy Study
Implementation; Notice of Opportunity for Hearing",Notice,Notice of Opportunity of Hearing,2003-12-12T05:00:00Z,2003,12,,,2025-03-13T19:16:21Z,03-20241,0,0,0900006480493c5c
FDA-2003-N-0102-0001,FDA,FDA-2003-N-0102,Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing,Notice,NPH-Notice of Opportunity of Hearing,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-09-09T03:59:59Z,2009-08-10T22:27:34Z,,0,0,090000648048405a
FDA-2003-N-0102-0002,FDA,FDA-2003-N-0102,See FDA-2003-N-0102-0001,Notice,NPH-Notice of Opportunity of Hearing,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-09-09T03:59:59Z,2009-08-10T22:32:45Z,,0,0,09000064804840a6
FDA-2000-N-0224-0002,FDA,FDA-2000-N-0224,Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Final Rule,Notice,Notice of Final Rule,2003-12-12T05:00:00Z,2003,12,2003-12-09T05:00:00Z,,2015-11-17T15:33:29Z,,0,0,09000064804d5428
FDA-2003-N-0162-0002,FDA,FDA-2003-N-0162,"Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in the New Animal Drug Regulations; Drug Efficacy Study
Implementation; Notice of Opportunity for Hearing; Correction",Notice,Correction,2003-12-12T05:00:00Z,2003,12,2003-10-07T04:00:00Z,2003-11-07T04:59:59Z,2025-03-14T14:23:01Z,03-25343,0,0,09000064804885a9
FDA-2003-N-0208-0003,FDA,FDA-2003-N-0208,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Electronic Records; Electronic,Notice,Notice of Approval,2003-12-12T05:00:00Z,2003,12,,,2025-02-25T16:12:07Z,03-29071,0,0,090000648048bd0c
FDA-2003-N-0300-0002,FDA,FDA-2003-N-0300,"Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in the New Animal Drug Regulations; Drug Efficacy Study
Implementation; Notice of Opportunity for Hearing; Correction",Notice,Correction,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-11-07T04:59:59Z,2025-03-13T19:30:24Z,03-25343,0,0,0900006480493c7d
FDA-1978-N-0027-0075,FDA,FDA-1978-N-0027,Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment,Notice,Notice of Final Rule,2003-12-09T05:00:00Z,2003,12,2003-12-09T05:00:00Z,2004-02-10T04:59:59Z,2019-08-01T14:04:49Z,03-30394,0,0,0900006480560e40
FDA-2003-N-0251-0008,FDA,FDA-2003-N-0251,"Agency Information Collection Activities; Announcement of the Office of Management and Budget Approval; Inspection by Accredited Persons Program Under the Medical Device User Fee and Modernization Act of
2002",Notice,General Notice,2003-12-09T05:00:00Z,2003,12,,,2025-02-25T12:43:16Z,03-30534,0,0,090000648048f647
FDA-2003-N-0195-0001,FDA,FDA-2003-N-0195,Amending the MedWatch Forms to Collect Postmarketing Adverse Event Data Relating to Race and Ethnicity,Notice,Request for Comments,2003-12-09T05:00:00Z,2003,12,2003-12-08T05:00:00Z,2004-02-07T04:59:59Z,2025-06-19T09:00:11Z,03-30300,0,0,090000648048b34f
FDA-2003-N-0439-0001,FDA,FDA-2003-N-0439,Agency Information Collection Activities: Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point; Procedures for the Safe and Sanitary Processing and Importing of Juice,Notice,60 Day Proposed Information Collection,2003-12-09T05:00:00Z,2003,12,2003-12-08T05:00:00Z,2004-02-07T04:59:59Z,2025-06-19T09:00:11Z,03-30302,0,0,09000064804a23ed
FDA-1998-F-0011-0001,FDA,FDA-1998-F-0011,FDA,Notice,NFR-Notice of Final Rule,2003-12-08T05:00:00Z,2003,12,2003-11-20T05:00:00Z,2004-01-21T04:59:59Z,2008-05-16T21:24:31Z,,0,0,0900006480559553
FDA-2003-N-0042-0003,FDA,FDA-2003-N-0042,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Environmental Impact Considerations,Notice,Notice of Approval,2003-12-08T05:00:00Z,2003,12,,,2025-02-25T18:00:54Z,03-29068,0,0,0900006480481755
FDA-2002-D-0222-0003,FDA,FDA-2002-D-0222,FDA,Notice,NAD-Notice of Availability of Data,2003-12-08T05:00:00Z,2003,12,2003-11-20T05:00:00Z,,2008-04-12T01:17:30Z,,0,0,0900006480497115
FDA-1993-D-0019-0002,FDA,FDA-1993-D-0019,FDA,Notice,NAD-Notice of Availability of Data,2003-12-08T05:00:00Z,2003,12,2003-11-21T05:00:00Z,,2008-05-16T23:22:51Z,,0,0,09000064804faa28
FDA-2000-D-0075-0002,FDA,FDA-2000-D-0075,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Suggested Documentation for Substantiating Whether Foods Have or Have Not Been Developed Using Bioengineering; Withdrawal,Notice,NWL-Notice of Withdrawl,2003-12-08T05:00:00Z,2003,12,2003-11-20T05:00:00Z,,2010-04-28T20:00:53Z,,0,0,09000064804b7783
FDA-2003-N-0027-0003,FDA,FDA-2003-N-0027,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Submission of Petitions: Food Additive, Color Additive (Including Labeling), and Generally Recognized as Safe Affirmation; and Electronic
Submission Using FDA Forms 3503 and 3504",Notice,Notice of Approval,2003-12-05T05:00:00Z,2003,12,,,2025-02-26T13:28:41Z,03-30029,0,0,0900006480481418
FDA-2003-E-0329-0005,FDA,FDA-2003-E-0329,Determination of Regulatory Review Period for Purposes of Patent Extension; STRATTERA,Notice,General Notice,2003-12-05T05:00:00Z,2003,12,2003-12-03T05:00:00Z,,2025-10-28T17:50:57Z,03-30028,0,0,0900006480495953
FDA-2003-N-0239-0001,FDA,FDA-2003-N-0239,Civil Money Penalties Hearings; Maximum Penalty Amounts and Compliance With the Federal Civil Penalties Inflation Adjustment Act,Notice,NPR-Notice of Proposed Rule-Making,2003-12-03T05:00:00Z,2003,12,2003-12-01T05:00:00Z,2004-02-18T04:59:59Z,2025-03-13T12:54:50Z,03-29741,0,0,090000648048e6d6
FDA-2003-D-0038-0001,FDA,FDA-2003-D-0038,FDA,Notice,NAD-Notice of Availability of Data,2003-12-03T05:00:00Z,2003,12,2003-11-28T05:00:00Z,,2008-04-12T00:54:16Z,,0,0,09000064804816dc
FDA-2003-N-0158-0004,FDA,FDA-2003-N-0158,Agency Information Collection Activities; Announcement of OMB Approval; Agreement for Shipment of Devices for Sterilization,Notice,Notice of Approval,2003-12-03T05:00:00Z,2003,12,,,2025-03-03T20:41:36Z,03-29745,0,0,0900006480487a38
FDA-2003-N-0395-0003,FDA,FDA-2003-N-0395,Agency Information Collection Activities; Announcement of OMB Approval; Export of Medical Devices-Foreign Letters of Approval,Notice,Notice of Approval,2003-12-03T05:00:00Z,2003,12,,,2025-03-04T15:19:44Z,03-29743,0,0,09000064804a1950
FDA-2003-N-0052-0001,FDA,FDA-2003-N-0052,"Dental Devices; Gold Based Alloys, Precious Metal Alloys, and Base Metal Alloys; Designation of Special Controls",Notice,NPR-Notice of Proposed Rule-Making,2003-12-03T05:00:00Z,2003,12,2003-12-01T05:00:00Z,2004-03-02T04:59:59Z,2025-06-10T09:00:17Z,03-29739,0,0,0900006480481a12
FDA-2003-E-0262-0004,FDA,FDA-2003-E-0262,Determination of Regulatory Review Period for Purposes of Patent Extension; DERAMAXX,Notice,General Notice,2003-12-03T05:00:00Z,2003,12,2003-12-01T05:00:00Z,,2025-10-23T23:36:46Z,03-29742,0,0,090000648049048b
FDA-2003-F-0055-0001,FDA,FDA-2003-F-0055,Vulcan Chemicals; Filing of Food Additive Petition,Notice,Notice of Filing,2003-12-03T05:00:00Z,2003,12,2003-12-01T05:00:00Z,2004-01-01T04:59:59Z,2025-11-03T20:00:57Z,03-29744,0,0,0900006480481a75
FDA-2002-D-0260-0003,FDA,FDA-2002-D-0260,FDA,Notice,NAD-Notice of Availability of Data,2003-12-02T05:00:00Z,2003,12,2003-12-01T05:00:00Z,2004-03-02T04:59:59Z,2008-04-12T01:17:35Z,,0,0,090000648049c625
FDA-2003-E-0067-0004,FDA,FDA-2003-E-0067,Determination of Regulatory Review Period for Purposes of Patent Extension; ELOXATIN,Notice,General Notice,2003-12-02T05:00:00Z,2003,12,2003-12-02T05:00:00Z,,2025-10-23T19:35:22Z,03-29928,0,0,0900006480481d4d
FDA-2002-N-0017-0002,FDA,FDA-2002-N-0017,FDA,Notice,NFR-Notice of Final Rule,2003-12-02T05:00:00Z,2003,12,2003-12-01T05:00:00Z,,2008-04-12T01:20:13Z,,0,0,09000064804889a3
FDA-1999-N-0134-0114,FDA,FDA-1999-N-0134,FDA,Notice,NCR-Notice of Correction,2003-12-02T05:00:00Z,2003,12,2003-12-01T05:00:00Z,,2008-04-25T00:17:00Z,,0,0,09000064804aeca6
FDA-2003-D-0373-0001,FDA,FDA-2003-D-0373,FDA,Notice,NAD-Notice of Availability of Data,2003-12-02T05:00:00Z,2003,12,2003-12-02T05:00:00Z,2004-03-02T04:59:59Z,2008-04-12T00:55:35Z,,0,0,09000064804990be
FDA-1999-N-0134-0116,FDA,FDA-1999-N-0134,FDA,Notice,NAD-Notice of Availability of Data,2003-12-02T05:00:00Z,2003,12,2003-12-01T05:00:00Z,,2008-04-25T00:16:58Z,,0,0,09000064804aecaa
FDA-2003-E-0061-0004,FDA,FDA-2003-E-0061,Determination of Regulatory Review Period for Purposes of Patent Extension; INVANZ,Notice,General Notice,2003-12-02T05:00:00Z,2003,12,2003-12-02T05:00:00Z,,2025-10-24T19:12:22Z,03-29929,0,0,0900006480481aed
FDA-2003-E-0261-0004,FDA,FDA-2003-E-0261,Determination of Regulatory Review Period for Purposes of Patent Extension; LEXAPRO,Notice,General Notice,2003-12-02T05:00:00Z,2003,12,2003-12-02T05:00:00Z,,2025-10-24T22:03:18Z,03-29927,0,0,0900006480490349
FDA-2003-D-0376-0001,FDA,FDA-2003-D-0376,FDA,Notice,NAD-Notice of Availability of Data,2003-11-28T05:00:00Z,2003,11,2003-11-25T05:00:00Z,,2008-04-12T00:55:39Z,,0,0,09000064804994a5
FDA-2002-E-0285-0002,FDA,FDA-2002-E-0285,Determination of Regulatory Review Period for Purposes of Patent Extension; XIGRIS,Notice,General Notice,2003-11-28T05:00:00Z,2003,11,2003-11-25T05:00:00Z,,2025-10-02T18:39:58Z,03-29333,0,0,090000648049ebf6
FDA-2003-E-0168-0003,FDA,FDA-2003-E-0168,Determination of Regulatory Review Period for Purposes of Patent Extension; XIGRIS,Notice,Determinations,2003-11-28T05:00:00Z,2003,11,2003-11-25T05:00:00Z,,2025-10-27T18:41:47Z,03-29333,0,0,0900006480488d36
FDA-2003-N-0161-0026,FDA,FDA-2003-N-0161,"Food Labels, Packaging, Restaurants, and Weight Management; Public Workshop; Amendment of Notice",Notice,NM-Notice of Meeting,2003-11-28T05:00:00Z,2003,11,2003-11-19T05:00:00Z,2003-12-13T04:59:59Z,2009-11-21T23:14:33Z,,0,0,090000648048807f
FDA-2003-N-0045-0001,FDA,FDA-2003-N-0045,FDA,Notice,NPR-Notice of Proposed Rule-Making,2003-11-28T05:00:00Z,2003,11,2003-11-25T05:00:00Z,2004-01-27T04:59:59Z,2008-04-12T00:58:08Z,,0,0,09000064804817a5
FDA-2001-P-0123-0001,FDA,FDA-2001-P-0123,FDA - Notice of Meeting,Notice,NM-Notice of Meeting,2003-11-28T05:00:00Z,2003,11,2003-11-24T05:00:00Z,,2009-07-17T19:32:07Z,,0,0,09000064804bcde3
FDA-1998-D-0001-0001,FDA,FDA-1998-D-0001,FDA,Notice,NAD-Notice of Availability of Data,2003-11-28T05:00:00Z,2003,11,2003-11-25T05:00:00Z,,2008-05-16T21:17:53Z,,0,0,09000064805585b6
FDA-1999-N-0069-0002,FDA,FDA-1999-N-0069,Public Information Regulations; Correction,Notice,Correction,2003-11-28T05:00:00Z,2003,11,,,2024-10-21T18:57:38Z,03-28985,0,0,09000064804a6860
FDA-2003-D-0144-0009,FDA,FDA-2003-D-0144,FDA,Notice,N-Notice,2003-11-28T05:00:00Z,2003,11,2003-11-20T05:00:00Z,2004-01-21T04:59:59Z,2008-04-12T00:54:35Z,,0,0,09000064804868b9
FDA-2003-N-0046-0001,FDA,FDA-2003-N-0046,Electronic Submissions of Food Contact Notifications; Notice of Pilot Project,Notice,General Notice,2003-11-28T05:00:00Z,2003,11,2003-11-26T05:00:00Z,,2025-06-19T09:00:11Z,03-29462,0,0,0900006480481881
FDA-2003-E-0263-0003,FDA,FDA-2003-E-0263,Determination of Regulatory Review Period for Purposes of Patent Extension; ABILIFY,Notice,Determinations,2003-11-28T05:00:00Z,2003,11,2003-11-26T05:00:00Z,,2025-10-23T17:25:51Z,03-29464,0,0,09000064804904a6
FDA-2003-D-0203-0001,FDA,FDA-2003-D-0203,FDA,Notice,NAD-Notice of Availability of Data,2003-11-25T05:00:00Z,2003,11,2003-11-21T05:00:00Z,,2008-04-12T00:54:59Z,,0,0,090000648048b8ac
FDA-2003-N-0311-0002,FDA,FDA-2003-N-0311,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the
Safe and Sanitary Processing and Importing of Fish and Fishery Products",Notice,30 Day Proposed Information Collection,2003-11-25T05:00:00Z,2003,11,2003-11-21T05:00:00Z,2003-12-25T04:59:59Z,2025-03-13T18:25:15Z,03-29195,0,0,0900006480494bd0
FDA-2003-N-0390-0001,FDA,FDA-2003-N-0390,Agency Information Collection Activities; Proposed Collection; Comment Request; Focus Groups as Used by the Food and Drug Administration,Notice,60 Day Proposed Information Collection,2003-11-25T05:00:00Z,2003,11,2003-11-24T05:00:00Z,2004-01-24T04:59:59Z,2025-06-17T22:09:36Z,03-29197,0,0,09000064804a1038
FDA-2002-N-0233-0040,FDA,FDA-2002-N-0233,FDA,Notice,NCR-Notice of Correction,2003-11-21T05:00:00Z,2003,11,2003-11-06T05:00:00Z,,2008-04-12T01:23:39Z,,0,0,090000648049879f
FDA-2003-D-0037-0001,FDA,FDA-2003-D-0037,FDA,Notice,NAD-Notice of Availability of Data,2003-11-21T05:00:00Z,2003,11,2003-11-06T05:00:00Z,,2008-04-12T00:54:15Z,,0,0,09000064804816c9
FDA-2002-N-0323-0034,FDA,FDA-2002-N-0323,"Interim Final Regulations Implementing Title III, Subtitle A, of Public Health Security and Bioterrorism Preparedness and Response Act of 2002-Section 305: Registration of Food Facilities and Section 307: Prior Notice of Imported Food Shipments; Notice of Public Meeting; Correction",Notice,NCR-Notice of Correction,2003-11-21T05:00:00Z,2003,11,2003-11-06T05:00:00Z,,2009-10-08T19:10:00Z,,0,0,09000064804a0938
FDA-1996-D-0048-0002,FDA,FDA-1996-D-0048,FDA,Notice,NAD-Notice of Availability of Data,2003-11-21T05:00:00Z,2003,11,2003-11-13T05:00:00Z,,2008-05-16T22:15:27Z,,0,0,09000064804fc7bc
FDA-1999-N-0134-0113,FDA,FDA-1999-N-0134,FDA,Notice,NM-Notice of Meeting,2003-11-21T05:00:00Z,2003,11,2003-11-06T05:00:00Z,,2008-04-25T00:16:59Z,,0,0,09000064804aeca4
FDA-2003-N-0250-0001,FDA,FDA-2003-N-0250,"Agency Information Collection Activities; Proposed Collection; Comment Request; Mammography Facilities, Standards, and Lay Summaries for Patients",Notice,60 Day Proposed Information Collection,2003-11-21T05:00:00Z,2003,11,2003-11-07T05:00:00Z,2004-01-07T04:59:59Z,2025-06-16T20:03:20Z,,0,0,090000648048f4d2
FDA-2003-P-0120-0002,FDA,FDA-2003-P-0120,Notice of Determination,Notice,N-Notice,2003-11-18T05:00:00Z,2003,11,2003-11-18T05:00:00Z,2003-11-18T04:59:59Z,2024-10-30T21:35:20Z,68FR65074,0,0,0900006480485a41
FDA-2003-N-0317-0001,FDA,FDA-2003-N-0317,Medical Devices; Effective Date of Requirement for Premarket Approval for Three Class III Preamendments Devices,Notice,NPR-Notice of Proposed Rule-Making,2003-11-18T05:00:00Z,2003,11,2003-11-18T05:00:00Z,2004-02-18T04:59:59Z,2025-06-16T16:54:31Z,03-28741,0,0,09000064804953cb
FDA-2003-N-0319-0001,FDA,FDA-2003-N-0319,Agency Information Collection Activities; Proposed Collection; Comment Request; Study to Measure the Compliance of Prescribers With the Contraindication of the Use of Triptans in Migraine Headache Patients With Vascular Disease,Notice,60 Day Proposed Information Collection,2003-11-17T05:00:00Z,2003,11,2003-11-17T05:00:00Z,2004-01-17T04:59:59Z,2025-06-25T15:30:11Z,,0,0,0900006480495652
FDA-2003-N-0310-0001,FDA,FDA-2003-N-0310,Agency Emergency Processing Under Office of Management and Budget Review; Experimental Study of Health Claim Disclaimers on Foods,Notice,General Notice,2003-11-14T05:00:00Z,2003,11,2003-11-10T05:00:00Z,2003-12-11T04:59:59Z,2025-06-17T23:18:09Z,03-28196,0,0,0900006480494a8f
FDA-2003-D-0433-0001,FDA,FDA-2003-D-0433,FDA,Notice,NAD-Notice of Availability of Data,2003-11-13T05:00:00Z,2003,11,2003-11-12T05:00:00Z,2003-12-16T04:59:59Z,2008-04-12T00:55:51Z,,0,0,09000064804a2315
FDA-2001-B-0228-0004,FDA,FDA-2001-B-0228,FDA,Notice,NAD-Notice of Availability of Data,2003-11-13T05:00:00Z,2003,11,2003-11-12T05:00:00Z,,2008-04-25T02:37:02Z,,0,0,09000064804e59fc
FDA-2002-D-0091-0003,FDA,FDA-2002-D-0091,FDA,Notice,NAD-Notice of Availability of Data,2003-11-13T05:00:00Z,2003,11,2003-11-12T05:00:00Z,,2008-04-12T01:16:26Z,,0,0,090000648048e1bd
FDA-2003-N-0382-0001,FDA,FDA-2003-N-0382,Agency Information Collection Activities; Proposed Collection; Comment Request; Food Additive Petitions,Notice,60 Day Proposed Information Collection,2003-11-13T05:00:00Z,2003,11,2003-11-10T05:00:00Z,2004-01-13T04:59:59Z,2025-06-16T18:57:40Z,03-28252,0,0,090000648049a04b
FDA-2003-N-0094-0001,FDA,FDA-2003-N-0094,Agency Emergency Processing Request Under OMB Review; Experimental Study of Trans Fat Claims on Foods,Notice,General Notice,2003-11-12T05:00:00Z,2003,11,2003-11-10T05:00:00Z,2003-12-11T04:59:59Z,2025-06-17T19:40:58Z,03-28194,0,0,0900006480483621
FDA-2003-N-0438-0001,FDA,FDA-2003-N-0438,Agency Emergency Processing Request Under Office of Management and Budget Review; Experimental Study of Possible Footnotes and Cuing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosure on the Nutrition Facts Panel,Notice,30 Day Proposed Information Collection,2003-11-12T05:00:00Z,2003,11,2003-11-10T05:00:00Z,2003-12-11T04:59:59Z,2025-06-18T09:00:04Z,03-28195,0,0,09000064804a23bf
FDA-2003-D-0200-0001,FDA,FDA-2003-D-0200,FDA,Notice,NAD-Notice of Availability of Data,2003-11-12T05:00:00Z,2003,11,2003-11-07T05:00:00Z,,2008-04-12T00:54:56Z,,0,0,090000648048b7fb
FDA-2002-P-0127-0003,FDA,FDA-2002-P-0127,FDA,Notice,N-Notice,2003-11-12T05:00:00Z,2003,11,2003-11-07T05:00:00Z,,2008-04-12T01:26:40Z,,0,0,090000648049053d
FDA-1999-N-0098-0001,FDA,FDA-1999-N-0098,"Notice of Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; ""Draft Guidance for Industry: Reports on the Status of Postmarketing Studies - Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997",Notice,N-Notice,2003-11-10T05:00:00Z,2003,11,2003-11-04T05:00:00Z,2003-12-06T04:59:59Z,2024-10-03T16:08:25Z,65FR64607,0,0,09000064804a6b1a
FDA-2002-P-0245-0002,FDA,FDA-2002-P-0245,FDA Determination that Wydase (Hyaluronidase) Inj. was not Withdrawn for Safety or Effectiveness Reasons 68 FR 62810,Notice,N-Notice,2003-11-10T05:00:00Z,2003,11,2003-11-05T05:00:00Z,,2016-04-24T16:19:16Z,68,0,0,090000648049a9c3
FDA-2003-M-0216-0001,FDA,FDA-2003-M-0216,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2003-11-10T05:00:00Z,2003,11,2003-11-05T05:00:00Z,,2025-04-16T19:48:25Z,03-27882,0,0,090000648048c897
FDA-2003-N-0044-0005,FDA,FDA-2003-N-0044,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Impact of Risk Management Programs on the Practice of Pharmacy,Notice,Notice of Approval,2003-11-10T05:00:00Z,2003,11,,,2025-02-18T21:15:36Z,03-27881,0,0,0900006480481790
FDA-2000-D-0075-0001,FDA,FDA-2000-D-0075,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Suggested Documentation for Substantiating Whether Foods Have or Have Not Been Developed Using Bioengineering,Notice,N-Notice,2003-11-07T05:00:00Z,2003,11,2003-10-31T05:00:00Z,2003-12-02T04:59:59Z,2015-10-10T19:27:31Z,,0,0,09000064804b0347
FDA-2003-D-0146-0001,FDA,FDA-2003-D-0146,"Guidance for Industry on Product Recalls, Including Removals and Corrections; Availability",Notice,NAD-Notice of Availability of Data,2003-11-07T05:00:00Z,2003,11,2003-11-07T05:00:00Z,,2008-04-14T01:44:41Z,,0,0,0900006480486c45
FDA-2003-D-0148-0001,FDA,FDA-2003-D-0148,FDA,Notice,NAD-Notice of Availability of Data,2003-11-07T05:00:00Z,2003,11,2003-10-30T05:00:00Z,,2008-04-12T00:54:42Z,,0,0,0900006480486e7e
FDA-2003-D-0148-0003,FDA,FDA-2003-D-0148,FDA,Notice,NFR-Notice of Final Rule,2003-11-07T05:00:00Z,2003,11,2003-10-30T05:00:00Z,,2008-04-12T00:54:42Z,,0,0,0900006480486ee1
FDA-2003-N-0156-0001,FDA,FDA-2003-N-0156,Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling Regulations,Notice,60 Day Proposed Information Collection,2003-11-07T05:00:00Z,2003,11,2003-10-31T05:00:00Z,2003-12-31T04:59:59Z,2025-06-16T23:47:37Z,03-27388,0,0,09000064804877fb
FDA-2003-N-0452-0001,FDA,FDA-2003-N-0452,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Certain Biologics
Labeling",Notice,60 Day Proposed Information Collection,2003-11-07T05:00:00Z,2003,11,2003-10-31T05:00:00Z,2003-12-02T04:59:59Z,2025-03-12T19:49:21Z,03-27389,0,0,09000064804a25cb
FDA-2003-D-0306-0001,FDA,FDA-2003-D-0306,Draft Guidance for Industry on Powder Blends and Finished Dosage Units Stratified In-Process Dosage Unit Sampling and Assessment,Notice,Notice of Availability,2003-11-07T05:00:00Z,2003,11,2003-11-07T05:00:00Z,2004-03-09T04:59:59Z,2014-07-15T17:55:28Z,,0,0,0900006480494496
FDA-2003-D-0031-0001,FDA,FDA-2003-D-0031,FDA,Notice,NAD-Notice of Availability of Data,2003-11-04T05:00:00Z,2003,11,2003-11-04T05:00:00Z,2004-01-06T04:59:59Z,2008-04-12T00:54:06Z,,0,0,090000648048155f